Rodrigo O. Cavagna
Barreto, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies.
Journal: The oncologist
Published: October 20, 2023
Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC.
Journal: Translational oncology
Published: July 18, 2023
Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: October 27, 2022
Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: August 11, 2021
Frequency of KRAS p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer.
Journal: JCO global oncology
Published: May 06, 2021
Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients.
Journal: Translational lung cancer research
Published: February 11, 2021
EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Journal: Thoracic cancer
Published: June 29, 2020
Lack of KBTBD4 Mutations in Molecularly Classified Brazilian Medulloblastomas.
Journal: Journal of neuropathology and experimental neurology
Published: March 21, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026